Tommie Reerink

Stock Analyst at Goldman Sachs

(1.98)
# 2,785
Out of 4,825 analysts
3
Total ratings
66.67%
Success rate
0.18%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $7.91
Upside: +39.06%